A novel subcutaneous CAR-T therapy for the treatment of hematological malignancies

An Insight Into Ctx130: A Novel Allogeneic Car-t Cell Therapy

Novel Targets In Car-t Therapy For Multiple Myeloma: Integrin Beta-7 & Cd98 Heavy Chain

Allo-715: Novel Allogenic Car T-cell Therapy In Myeloma

Novel Car-t Constructs Being Investigated For The Treatment Of All

Novel Car T-cell Therapies For Hematological Malignancies: Exploring New Targets

Novel Immunotherapies For Myeloma Treatment

Phase 1 Trials Of Novel Car T-cells For Leukemia

C-car088: A Novel Car T-cell Therapy For R/r Myeloma

Novel Allo-cart Therapies And Their Role In The Treatment Of Hematological Malignancies

Novel Car-t Constructs Emerging In Multiple Myeloma For Patients Who Experience Loss Of Bcma

The Changing Role Of Autosct In The Treatment Of Multiple Myeloma In The Era Of Novel Agents

The Safety And Efficacy Of Auto1/22: A Novel Co-transduced Cd19/22 Car-t Therapy For R/r All

Horizon Scan Of Car-t In Multiple Myeloma

Early Treatment And Novel Therapeutic Targets For Multiple Myeloma

Car-t Cells: Current Climate And Future Perspectives In Multiple Myeloma

Update On Cartitude-1: Car-t In Rrmm

Current Car-t Climate In Multiple Myeloma

Myeloma: Bites & Cars

The Future Of Multiple Myeloma Treatment